Down More Than 20% From Its High, Is Broadcom Stock a Buy?

Broadcom shares are down more than 7% over the past month and more than 20% from highs near $500 after its June 3 earnings report failed to excite investors. Revenue rose 48% year over year to more than $22 billion, and AI semiconductor revenue jumped 143%, but the stock still trades at 66x trailing earnings, leaving valuation as the main concern. The article argues the pullback may improve the long-term case, with a PEG ratio of 0.72, but near-term sentiment remains cautious.

Analysis

The market is not questioning demand; it is questioning the price paid for that demand. In a name like AVGO, the first-order reaction to a solid print is often muted because incremental beats do little to justify multiple expansion once the stock has already capitalized several years of AI enthusiasm. The more important second-order effect is that high expectations compress the window for error: even if fundamentals remain strong, any sign of normalization in AI order growth, gross margin mix, or capex digestion can trigger disproportionate de-risking.

This also matters for the broader AI complex. If the market decides AVGO is the "too-expensive beneficiary" of AI infrastructure, capital may rotate toward the upstream picks-and-shovels names with clearer scarcity value and less valuation fragility, or toward semis with more torque to unit growth rather than narrative premium. NVDA and INTC are not direct reads here, but AVGO’s post-earnings weakness reinforces a key positioning signal: investors may be pruning crowded AI winners and looking for cleaner asymmetry elsewhere in the chain.

The contrarian view is that the drawdown may be more about multiple compression than fundamental deterioration, which makes the next few quarters critical. If AI revenue continues to compound at high double digits and management avoids any guide-down in growth cadence, the stock can re-rate back quickly because the earnings power is still expanding into a very large base. But if growth merely stays strong instead of accelerating, the stock likely trades sideways-to-down for months as valuation mean reversion does the work that fundamentals are no longer doing.

The risk/reward setup is therefore tactical, not heroic. This is not a clean "buy the dip" unless investors are willing to underwrite a long-duration AI platform story and tolerate 10-15% additional drawdown if sentiment de-risks again. The better near-term setup is to exploit valuation sensitivity with defined-risk structures rather than outright leverage.

Key Decisions for Investors

• Avoid adding to AVGO on the first bounce; wait for either a second leg down into a broader tech selloff or a post-earnings stabilization base over 2-4 weeks before re-entering. Risk/reward is poor until the market proves it will pay up for the growth again.
• If holding AVGO long-term, prefer a call spread rather than stock: buy AVGO 3-6 month calls financed with a higher strike sale to capture upside if AI growth re-accelerates, while limiting damage if multiple compression persists.
• Pair trade: long NVDA / short AVGO for the next 1-3 months if AI infrastructure spending remains strong but investors continue to punish premium-valued compounders. NVDA has cleaner sentiment support and more convexity to incremental upside surprise.
• For event-driven accounts, sell AVGO downside puts only after implied volatility normalizes; premium is likely elevated after the selloff, but the position should be sized for a 10-12% gap risk if guidance or AI spend expectations soften.
• Use AVGO weakness to rotate into less crowded AI enablers or second-derivative beneficiaries over the next quarter; the opportunity cost of owning the highest-multiple winner is rising as the market becomes less tolerant of perfection.